Brief: Lyell Immunopharma Q2 Net Income USD -45.809 Million
07/08/2024 21:05
Aug 07 (Reuters) - Lyell Immunopharma Q2 revenue USD 13 thousand. * Q2 operating expenses USD 51.541 million * Q2 adjusted net income USD -39.059 million * Q2 operating income USD -51.528 million
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma